Our research features two closely related development fields: brain circuit markers and neurofeedback technology. We aim to leverage AI to create innovative treatment pathways for depression, schizophrenia, autism, and other neurological disorders.
Main areas of development: (1) big-data analysis of large neuroimaging (fMRI) datasets with machine learning and AI to build cross-disorder brain circuit markers related to cognitive functions; (2) validating AI-neurofeedback technology with clinical state-of-the-art approach and building novel neurofeedback approaches with generative/adversarial AI.